European businesses are urging policymakers to intensify trade negotiations after U.S. President Donald Trump announced plans for a broad 30% tariff on European Union (EU) imports from August 2025. While companies across the continent are avoiding outright panic, the impending deadline for the new duties has injected volatility into financial markets and reignited fears of an all-out transatlantic trade war.

Trump’s announcement came at a time when U.S.-EU trade relations were already tense. The President stated his intention to increase tariffs on EU and Mexican goods starting August 1, amplifying pressure on Brussels to reach a deal and avoid potentially severe economic fallout. The U.S.-EU trading partnership, one of the world’s largest, amounted to $975.9 billion in two-way goods trade in 2024, according to the Office of the U.S. Trade Representative. The sudden escalation risks disrupting global supply chains and damaging industries on both sides of the Atlantic, particularly automotive, pharmaceuticals, and luxury goods.

Market Turbulence and Immediate Business Impact

The announcement immediately reverberated through European equity markets. Automakers were hit hardest, with shares in Volkswagen, BMW, Mercedes-Benz, Stellantis, Renault, and Porsche dipping by 1–2% in early trading. Volvo Car, citing the impact of tariffs, revealed it could no longer sell its ES90 model profitably in the United States and would take a $1.2 billion impairment charge as a result—leading its shares to plummet 4.7%.

The effects rippled through other sectors as well. French spirit maker Pernod Ricard, known for Jameson whiskey, saw shares fall 1.5% while Remy Cointreau dropped 4%. Luxury giant LVMH fell by 1.5% on worries over the U.S.-facing business. However, British competitor Diageo bucked the trend, with shares rising slightly on robust U.S. whiskey and tequila sales.

Other export-oriented sectors, including chemicals and food, reported smaller yet notable declines. Pernod Ricard, Remy Cointreau, LVMH, Nestle, Procter & Gamble, and Reckitt Benckiser all faced periods of downward pressure as investors weighed the real impact of an escalating tariff regime.

Complex Tariff Landscape Fuels Uncertainty

President Trump’s latest threatened 30% duty is set to be applied on top of an existing 27.5% U.S. import tax on European autos, which has been in force since April 2025, underscoring the exceptional pressure now facing transatlantic businesses. In a letter to European Commission President Ursula von der Leyen, Trump emphasized the new tariff would be independent of existing sectoral duties. Pharmaceutical companies are also bracing for possible new taxes, after enduring repeated threats of up to 200% levies this year, leading to a “wait and see” approach among executives and investors alike.

While the Trump administration has a track record of escalating trade disputes and subsequently revising deadlines or demands, the looming imposition date has prompted urgent calls for clarity and action. The term “TACO”—short for “Trump Always Chickens Out”—has even entered financial jargon, reflecting market skepticism that the President will follow through. Nevertheless, companies say they are fully mobilized, with most automakers and multinationals now operating “tariffs task forces” to run scenario planning and contingency exercises.

Negotiation or Trade War?

“The escalating tariff conflict with the USA poses a serious threat to many German companies,” warned Volker Treier, head of the German Chamber of Commerce and Industry (DIHK), as he urged policymakers to speed up negotiations. Business leaders across the EU are calling for tough but pragmatic solutions. Wolfgang Große Entrup, Managing Director of Germany’s chemical association VCI, commented, “Both sides must try to reach a fair agreement by 1 August. We should act and not wage trade wars.” Business voices are also emphasizing the need for Europe to strengthen its industrial base and conclude further free trade agreements to reduce dependency on the U.S. market.

Mercedes-Benz, echoing remarks from several European multinationals, stressed the critical importance of a U.S.-EU agreement for economic stability and transatlantic prosperity. “An agreement is crucial for the future economic success of both markets, and we urge all parties to work intensively toward a fast resolution,” the company said in a statement.

European officials have described Trump’s plan as “prohibitive to any trade,” while businesses continue to seek reassurance and predictability in an increasingly volatile policy environment. The risk of tit-for-tat escalation—potentially resulting in billions in lost exports and major production disruptions—remains a central fear for both manufacturers and financial markets.

Global Implications

The automotive and consumer goods sectors are among the most exposed, but the impact of any broad-based U.S. tariffs would inevitably ripple through global supply chains. Over 10% of EU auto exports—worth nearly $43 billion in 2024—were destined for the U.S., with many vehicles manufactured in Germany, France, and Sweden. Industry experts warn that higher tariffs could significantly erode profit margins, leading to price hikes for U.S. consumers or, as Volvo’s example shows, removal of models from the market altogether.

With global inflationary pressures already elevated and central banks cautious about monetary easing, the prospect of a fresh round of tariffs highlights wider economic vulnerabilities. The dollar’s recent volatility, partly fueled by tariff and trade fears, underscores the interconnectedness of global markets and the potentially far-reaching knock-on effects.

What Comes Next?

Analysts widely expect intense transatlantic negotiations to continue in the coming weeks, with many holding out hope for an 11th-hour compromise or extension. Trump’s past negotiation tactics—often using tariff threats as leverage to force concessions—leave open the possibility of a partial backtrack or phased implementation. Nevertheless, the lack of clarity is breeding caution, with companies accelerating contingency planning and warning of the need for rapid policy responses.

“We have a tariffs task force that has been doing a lot of scenario planning. We are in wait and see mode until something comes into force concretely,” said a senior executive in the European pharmaceutical sector.

European markets, businesses, and policymakers will be watching closely for signals from Washington and Brussels in the days ahead, wary of the high economic and political stakes if no resolution can be found.